Here, we report a novel antiviral function of DHX9, where it forms “antiviral granules” in the cytoplasm that can restrict MYXV in at least some human cancer cells by sequestering essential viral factors and thus restricting late stages of the replication cycle. The gene discussed is DHX9; the disease is cancer.